Trial intelligence / Profile preview

Mivacurium Doses for RSI in Emergency Surgery

NCT06072534Recruiting

Sponsor
Al-Azhar University
Start
Sep 2023
Primary completion
Jan 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of mivacurium (2 arms), sponsored by Al-Azhar University. Primary endpoint: Intubation conditions during RSI at 3 months. Started Sep 2023; status: recruiting.

02

Drugs

mivacurium

Beyond the preview

Go deeper on NCT06072534.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06072534.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call